
|Articles|September 1, 2003
- Volume 0 0
Learning Objectives
Advertisement
Learning Objectives
After reading these articles, the reader should be able to:
- Describe current and emerging pharmacologic options for lipid lowering therapy
- Explain how to intensify lipid-lowering therapy if necessary to achieve National Cholesterol Education Program goals
- Provide suggestions for effective patient counseling about lipid-lowering therapy and goals.
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
Operationalizing Epcoritamab-GemOx in Practice: A Focus on EPCORE NHL-2
2
Current and Emerging BCMAxCD3 Bispecifics
3
Amivantamab for EGFR-Mutated Metastatic Non–Small Cell Lung Cancer
4
Same Pathway, Different Profiles: Clinical Considerations for Alpelisib, Capivasertib, and Inavolisib
5